12/03/2024
5:15 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
1:44 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
1:27 PM | BioMarin Pharmaceutical (Subject)
Guyer Charles Greg (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
2:01 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/01/2024
3:50 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
3:51 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:29 PM | BioMarin Pharmaceutical (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G | |
|
09/24/2024
7:31 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:54 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
11:52 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
4:02 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2024
4:00 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
10:48 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
12:14 PM | BioMarin Pharmaceutical (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
07/01/2024
3:19 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:28 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:29 PM | BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
9:18 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
5:28 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
9:49 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
5:18 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
1:22 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
9:10 AM | BioMarin Pharmaceutical (Subject)
LAWLIS V BRYAN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
9:18 AM | BioMarin Pharmaceutical (Subject)
Mueller Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
9:28 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
9:36 AM | BioMarin Pharmaceutical (Subject)
Davis George Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
4:23 PM | BioMarin Pharmaceutical (Issuer)
Enyedy Mark J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:26 PM | BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:30 PM | BioMarin Pharmaceutical (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:33 PM | BioMarin Pharmaceutical (Issuer)
HOMBACH ROBERT J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:34 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:36 PM | BioMarin Pharmaceutical (Issuer)
PYOTT DAVID E I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:14 PM | BioMarin Pharmaceutical (Issuer)
Countouriotis Athena (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:20 PM | BioMarin Pharmaceutical (Issuer)
Dere Willard H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:06 PM | ANDERSON ELIZABETH M (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:08 PM | BioMarin Pharmaceutical (Issuer)
Bodem Barbara W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:33 PM | BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/22/2024
3:36 PM | BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
4:20 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
4:16 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
2:57 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad) I believe it’s going to power Elon Musk’s next AI revolution…
A revolution he believes will be worth more than $9 trillion.
That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. |
05/10/2024
9:11 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
9:54 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
4:58 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:40 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:45 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
4:37 PM | BioMarin Pharmaceutical (Subject)
Davis George Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
9:49 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2024
12:59 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:07 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
3:11 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
3:21 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
2:07 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
8:49 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024
8:54 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2024
3:24 PM | BioMarin Pharmaceutical (Filer)
| Form ARS | |
04/09/2024
3:07 PM | BioMarin Pharmaceutical (Filer)
| Form DEF 14A | |
04/09/2024
3:09 PM | BioMarin Pharmaceutical (Filer)
| Form DEFA14A | |
03/20/2024
4:13 PM | BioMarin Pharmaceutical (Issuer)
Slamon Dennis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:48 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:50 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:53 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:55 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:36 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:40 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:42 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:46 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:54 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:32 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:35 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
11:04 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
1:41 PM | BioMarin Pharmaceutical (Subject)
FUCHS HENRY J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
11:04 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:10 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:12 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:14 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:16 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:18 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:05 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
9:35 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
12:34 PM | BioMarin Pharmaceutical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2024
12:21 PM | BioMarin Pharmaceutical (Subject)
DODGE & COX (Filed by)
| Form SC 13G/A | |
02/12/2024
4:20 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
2:24 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/09/2024
4:46 PM | BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
| Form SC 13G | |
02/09/2024
9:36 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024
8:46 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
6:47 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:06 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
1:40 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
9:09 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Your bank is lying to you. (Ad) You might think you have your money in a high-yield savings account, but do you really? The national average APY on savings is just 0.58%, but you can get up to 5.0% APY online with these accounts. View the best savings account rates here |
01/09/2024
10:48 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/28/2023
12:00 PM | BioMarin Pharmaceutical (Issuer)
Countouriotis Athena (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
12:03 PM | BioMarin Pharmaceutical (Issuer)
Countouriotis Athena (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
12:11 PM | BioMarin Pharmaceutical (Issuer)
Enyedy Mark J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
12:13 PM | BioMarin Pharmaceutical (Issuer)
Enyedy Mark J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
12:15 PM | BioMarin Pharmaceutical (Issuer)
Bodem Barbara W. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
12:18 PM | BioMarin Pharmaceutical (Issuer)
Bodem Barbara W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:14 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
8:57 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
